Transfer of activation-dependent gene expression into T cell lines by recombinant adeno-associated virus
- 5 February 1999
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 6 (2), 182-189
- https://doi.org/10.1038/sj.gt.3300803
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Lack of Site-Specific Integration of the Recombinant Adeno-Associated Virus 2 Genomes in Human CellsHuman Gene Therapy, 1997
- Site-specific integration by adeno-associated virus.Proceedings of the National Academy of Sciences, 1996
- High-Efficiency Transfer of the T Cell Co-Stimulatory Molecule B7-2 to Lymphoid Cells Using High-Titer Recombinant Adeno-Associated Virus VectorsHuman Gene Therapy, 1995
- The cryptic life style of adenoassociated virusBioEssays, 1995
- X-Linked Agammaglobulinemia and Immunoglobulin Deficiency with Normal or Elevated IgM: Immunodeficiencies of B Cell Development and DifferentiationAdvances in Immunology, 1995
- Recombinant adeno-associated virus (rAAV)-mediated expression of a human gamma-globin gene in human progenitor-derived erythroid cells.Proceedings of the National Academy of Sciences, 1994
- Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.Journal of Clinical Investigation, 1994
- Adeno-associated virus vectors preferentially transduce cells in S phase.Proceedings of the National Academy of Sciences, 1994
- Prospects for the Use of Adeno-Associated Virus as a Vector for Human Gene TherapyHuman Gene Therapy, 1994
- Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood.The Journal of Experimental Medicine, 1994